Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2012 by Farmoquimica S.A..
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
Pharmagenix Projetos em Medicina Farmacêutica Ltda.
Information provided by (Responsible Party):
Farmoquimica S.A.
ClinicalTrials.gov Identifier:
NCT01421433
First received: August 18, 2011
Last updated: March 7, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: January 2013
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)